Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum

15 Jun 2017

Abstract excerpt

// Danielle M. Greenawalt 1,4 , Winnie S. Liang 2 Sakina Saif 1 , Justin Johnson 1 , Petar Todorov 1 , Austin Dulak 1 , Daniel Enriquez 2 , Rebecca Halperin 2 , Ambar Ahmed 1 , Vladislav Saveliev 3 , John Carpten 2 , David Craig 2 , J. Carl Barrett 1 , Brian Dougherty 1 , Michael Zinda 1 , Stephen Fawell 1 , Jonathan R. Dry 1 and Kate Byth 1 1 Oncology Innovative Medicines and Early Development, AstraZeneca R&D...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Chronic Lymphocytic Leukemia Research
Share to Genomic variations and chromosomal abnormalities

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29245897
DOI: 10.18632/oncotarget.18502

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrumPMID 29245897Read ↗

Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup.Semantic proximity Read ↗

Recurrent Mutations in Refractory/Relapsed Diffuse Large B-Cell Lymphoma by Targeted Gene Sequencing.Semantic proximity Read ↗

Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy ResistanceSemantic proximity Read ↗

The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs.Semantic proximity Read ↗

Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma.Semantic proximity Read ↗

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.Semantic proximity Read ↗

Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaSemantic proximity Read ↗

Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphomaSemantic proximity Read ↗

Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.Semantic proximity Read ↗

Genetic alterations and their clinical implications in DLBCLSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.